AU Stock MarketDetailed Quotes
ALA Arovella Therapeutics Ltd
- 0.140
- -0.005-3.45%
20min DelayMarket Closed Jun 28 16:00 AET
147.08MMarket Cap-10000P/E (Static)
0.150High0.140Low662.99KVolume0.145Open0.145Pre Close95.42KTurnover0.18552wk High0.08%Turnover Ratio1.05BShares0.04252wk Low-0.013EPS TTM118.80MFloat Cap360.698Historical HighLossP/E (Static)848.57MShs Float0.020Historical Low-0.014EPS LYR6.90%Amplitude--Dividend TTM46.67P/B1Lot Size--Div YieldTTM
About Arovella Therapeutics Ltd Company
Arovella Therapeutics Ltd is a biotechnology company focused on developing its invariant natural killer T (iNKT) cell therapy platform from Imperial College London to treat blood cancers and solid tumours.
Company Profile
SymbolALA
Company NameArovella Therapeutics Ltd
Founded1999
MarketASX
Employees14
Fiscal Year Ends06-30
Address62 Lygon Street Level 3
CityCarlton
CountryAustralia
Zip Code3053
Phone+61 398245254
Websitehttps://www.arovella.com
Share RegistryAUTOMIC REGISTRY SERVICES
477 Collins Street, MELBOURNE, VIC, AUSTRALIA, 3000
1300 288 664
Company Executives
- Name
- Position
- Salary
- Michael Baker
- Chief Executive Officer and Managing Director
- --
- Thomas (Tom) Duthy
- Non-Executive Chairman
- --
- Debora Barton
- Non-Executive Director
- --
- David Simmonds
- Non-Executive Director
- --
- Gary Phillips
- Non-Executive Director
- --
- Elizabeth Stoner
- Non-Executive Director
- --
- Phillip Hains
- Company Secretary
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
%Chg